It may be just one stepping stone to a cure, but the founder of BC Diabetes is seeing powerful results in ongoing clinical trials for individuals in the early stages of the disease.
Dr. Tom Elliott administered the study drug ustekinumab (Stelara) during trials in 2021 which showed promising results in treating early-stage type 1 diabetes.
The drug is a commonly prescribed medication proven effective in treating autoimmune diseases such as Crohn’s disease, colitis, and psoriasis.
Support local journalism today
Join thousands of other like-minded readers and sign up below to gain immediate & unlimited access to our news for the next 30 days – plus start receiving our newsletters.
Dialogue and debate are integral to a free society and we welcome and encourage you to share your views on the issues of the day. We ask that you be respectful of others and their points of view, refrain from personal attacks and stay on topic. To learn about our commenting policies and how our community-based moderation works, please read our Community Guidelines.
